Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Remote Patient Monitoring | Experimental | All participants who have successfully established remote data-sharing from their glucose monitors to the research team's Glooko account by conclusion of the one-month baseline period will advance to the six-month intervention period. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remote Patient Monitoring | Behavioral | Participants' glucose data will be monitored by the study team using population analytic reports. Participants who either have excessive hypoglycemia or hyperglycemia on these reports will be contacted by a pediatric endocrinologist (the principal investigator) to discuss any necessary adjustments to their home diabetes management plans. This intervention will be in addition to their usual care (regular visits at the UC Davis Pediatric Endocrinology clinic). |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of remote glucose monitoring for pediatric T1D patients who receive care at UC Davis Health | Proportion of participants who have successfully established remote glucose monitoring by the end of the baseline period. | 1 month baseline period |
| Change in hemoglobin A1c (HbA1c) | HbA1c at study completion minus the HbA1c at initiation | Initiation = 1 month after enrollment, Study completion = 7 months after enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Data-sharing experience survey | Survey asking about patient's experience with data-sharing | 1 month after enrollment |
| Target Glucose Range | Percentage of time spent in target glucose range (generated from continuous glucose monitor) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California-Davis | Sacramento | California | 95817 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36817610 | Derived | Crossen SS, Romero CC, Lewis C, Glaser NS. Remote glucose monitoring is feasible for patients and providers using a commercially available population health platform. Front Endocrinol (Lausanne). 2023 Feb 2;14:1063290. doi: 10.3389/fendo.2023.1063290. eCollection 2023. |
| Label | URL |
|---|---|
| Learn more or sign up for the study here! | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jan 27, 2023 | |
| Reset | Nov 10, 2023 | |
| Release | Dec 11, 2023 | |
| Reset | Jun 7, 2024 | |
| Release | Sep 22, 2025 | |
| Reset | Sep 24, 2025 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jan 27, 2023 | Nov 10, 2023 | |||
| Dec 11, 2023 |
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000098465 | Remote Patient Monitoring |
| ID | Term |
|---|---|
| D017216 | Telemedicine |
| D003695 | Delivery of Health Care |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Months 1-7 after enrollment |
| Hyperglycemic range | Percentage of time spent in hyperglycemic range (generated from continuous glucose monitor) | Months 1-7 after enrollment |
| Hypoglycemic range | Percentage of time spent in hypoglycemic range (generated from continuous glucose monitor) | Months 1-7 after enrollment |
| Overall continuous glucose monitor (CGM) wear time | Percentage of time spent wearing continuous glucose monitor (generated from continuous glucose monitor) | Months 1-7 after enrollment |
| Remote patient monitoring survey | Survey asking about patient's experience with remote patient monitoring | Month 7 after enrollment |
| Jun 7, 2024 |
| Sep 22, 2025 | Sep 24, 2025 |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |